Norgen Biotek Launches 10 New Kits for the Isolation of High-Quality Circulating Nucleic Acids from Blood, Plasma and Serum
Thorold, ON, February 02, 2010 -
Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily
on advancing powerful tools for
nucleic acids (NA) and protein purification,
today announced the launch of 10 new
kits for the fast and simple isolation
of nucleic acids from blood, plasma and serum, including circulating nucleic
acids. These kits provide fast, robust, reliable and simple procedures for
isolating and purifying high quality
macromolecules such as DNA, RNA, circulating NA and microRNA from a wide range
of sample volumes (100 µL up to 10 mL). The sensitivity and speed make these
kits very useful and powerful tools for a number of applications including the
detection of tumor biomarkers, viruses and microRNA detection by PCR, quantitative PCR, RT-PCR, microarrays, and next gen
sequencing.
Norgen’s blood/plasma/serum
kits utilize a convenient spin column format for nucleic acid purification, and
both fresh and frozen samples can be processed. In particular, the circulating
NA kits provide an advantage over other available kits in that they do not require extension tubes for the
purification of free circulating nucleic acids from large sample volumes.
Circulating NA present in 1 mL
– 10 mL inputs are concentrated
into final elution volumes of 50 – 200
m
L that can be used directly in sensitive downstream
applications, as the kits completely
remove all contaminants and inhibitors. These kits are also available in a
96-well format, allowing for even faster sample processing and high-throughput
purification of circulating NA, and can therefore be used in biomarker
discovery and in diagnostics.
"This
basket of new kits represents
an exciting addition to our line of
high quality products. These kits are unique in that
they allow for the reliable isolation
of all sizes of circulating NA
without the use of inhibitory and harmful phenol or chloroform.
Currently, we
have more than 70 kits for genomics and proteomics research
applications. Our mission is to bring to market innovative
Best-in-Class sample preparation kits that
can be used in research as well as in diagnostic applications.
Once again we are taking advantage of our unique technology in order to
develop
sensitive and user-friendly products for our customers” said Dr.
Haj-Ahmad, President & CEO of Norgen
Biotek.
About Norgen Biotek
Corp.
Norgen Biotek, an ISO 13485:2003andISO 9001:2008registered company, is
a rapidly growing privately-held
Canadian biotech company committed to providing innovative
products and services to the life sciences and pharmaceutical industry. Norgen
has developed technologies and products for the purification
of nucleic acids and proteins on both preparative
and industrial scales, including ready-to-use chromatography
resins and pre-packed chromatography
columns. Norgen is open to various
modality of business opportunity. Detailed information
about the company is available at www.norgenbiotek.com
or contact Dr. Yousef Haj-Ahmad, President & CEO, Norgen Biotek Corp.,
Phone: (905) 227-8848, Fax: (905) 227-1061, Email: yha@norgenbiotek.com.
posted: 2/2/2010
|